Search Results 101-110 of 15892 for GLP-1 agonist
Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes. Int J Cardiol. 2026 Feb 15; 445:134042 Epub ...
GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty. 2025 Aug ...
Mishra S, Persons PA, Bersoux S. Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? Cleve Clin J Med. 2025 Apr 1; 92 ( ...
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08. View PubMed ...
Three-year outcomes of glucagon-like peptide-1 agonists in atrial fibrillation with sarcoidosis and diabetes. Heart Rhythm. 2025 May 8 Epub 2025 May 08. View ...
Hunter Guevara LR, Beam WBB, Pasternak JJ. To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists.
2026 Jan 29; 21(1):33. View PubMed; Eshak N, Irani A, Sullivan M. Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real ...
Central alpha agonists. Central agonists. Examples of central-acting agents. Several central-acting agents are available. The best one for you depends on ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2025 Oct 1 Epub ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.